Abbott and Google Team Up: AI Health Coaching Meets Continuous Glucose Monitoring

Abbott and Google announced on August 11, 2026 a first-of-its-kind partnership that pairs Abbott’s Lingo over-the-counter continuous glucose monitor (CGM) with Google Health’s artificial intelligence, aiming to transform how everyday people understand and manage their metabolic health. The multi-year collaboration will connect glucose data from Lingo’s biowearable sensor into the Google Health app, where an AI-powered Health Coach will translate it into personalized, actionable guidance.

The deal is one of the clearest signals yet that consumer health tech is entering a new phase: instead of dashboards full of raw numbers, users get an AI layer that interprets their body’s data in context and tells them what to do about it.

What the Partnership Actually Does

The collaboration focuses on three areas, according to Abbott’s press release.

First, connecting glucose data to a more complete picture of health. Ongoing glucose insights from the Lingo CGM will be integrated into Google Health, letting users see glucose trends alongside other health and wellness metrics in a single unified experience. The goal is helping people understand their body’s response to daily habits — meals, workouts, sleep, stress — and make better lifestyle and nutrition choices in the moment.

Second, delivering AI-powered, personalized health guidance. Glucose insights will feed Google’s Health Coach, which will provide tailored, contextual recommendations designed to help users build sustainable habits around nutrition, activity, sleep, and recovery. For premium subscribers, the coach will interpret Lingo data alongside the other health signals Google already collects.

Third, establishing new science about metabolic health. The companies plan to conduct one of the largest real-world metabolic health studies to date, integrating continuous glucose data, wearable data, laboratory results, and survey responses to uncover connections between activity, sleep, wellbeing, and metabolic health. Abbott did not disclose how many people will be enrolled. The findings will inform both Google’s AI coaching and future Lingo product features.

Why It Matters: The Prediabetes Crisis

The timing is driven by sobering numbers. Prediabetes is one of the fastest-growing health crises in the United States, affecting more than 115 million American adults — over 2 in 5 adults — and approximately 8 in 10 of them are completely unaware they have it. Poor metabolic health is also linked to a cascade of chronic conditions including Type 2 diabetes, cardiovascular disease, and certain cancers.

“The biggest challenge in healthcare isn’t treating disease—it’s helping people stay healthier longer,” said Olivier Ropars, divisional vice president of Abbott’s Lingo business. “Abbott’s leadership in biowearables and Google’s expertise in AI and consumer technology create a powerful opportunity to make personalized insights available at unprecedented scale.”

The premise of the partnership is that continuous glucose data — historically a tool for insulin-dependent diabetes management — can become a prevention instrument for the general population when an AI makes it interpretable. Lingo targets adults 18 and older who are not using insulin and want to make informed decisions about their health.

The Google Health Angle

Google’s Health app is built on its 2021 acquisition of Fitbit for $2.1 billion, and the Health Coach is the company’s flagship consumer AI health product. It requires a Google Health Premium subscription, the Google Health app, and an internet connection. The company notes the feature is “not intended for medical purposes” and that users should check responses for accuracy.

“The future of health lies in turning complex health information into personalized guidance that people can use every day,” said Rishi Chandra, vice president and general manager of Google Health. “Abbott and Google are creating a more complete picture of health that can help people better understand the connections between their daily habits and overall well-being.”

Lingo health integrations will continue to roll out in the Google Health app later in 2026.

Competitive Context: The AI Health Coach Race Is On

The Abbott–Google deal does not exist in a vacuum. Competitor Dexcom is participating in a U.S. Food and Drug Administration pilot program testing an AI-enabled glucose health program designed to help people improve glycemic control, and added generative AI features to its own over-the-counter CGMs back in December 2024. Samsung has been building health foundation models into its own ecosystem. Apple, Oura, and Whoop are all racing to add AI coaching layers on top of wearable data.

What distinguishes this partnership is the combination of a regulated, medically credible sensor platform (Abbott’s CGM lineage) with Google’s AI and its massive consumer distribution. Abbott brings the hardware and clinical trust; Google brings the interpretation layer and the reach. If the integration works as promised, it puts continuous glucose interpretation in front of a far larger audience than either company could reach alone.

The Open Questions

There are caveats worth watching. Neither company has published the enrollment size or methodology of the planned metabolic health study, and it remains to be seen how the AI coach’s recommendations will handle the enormous individual variability in glucose responses. Privacy advocates will also scrutinize how sensitive metabolic data flows between a medical device maker and a company whose core business is data-driven advertising — Google says Health Coach features work independently of its other products, but the optics of combining biowearable data with Google’s ecosystem will invite questions.

There is also the engagement question that haunts all consumer health apps: a 2024-vintage CGM debut and an AI coach can generate insights, but sustained behavior change is notoriously hard. The partnership’s large-scale study is partly an admission that the science of what actually drives habit change around glucose data is still being built.

Still, as a template for where consumer health AI is heading — sensor data in, personalized coaching out — the Abbott–Google partnership is one of the most concrete deployments yet announced.